Abstract:
FIG. 1 is a top, front, and left side perspective view of a children's electric motorcycle embodying my new design; FIG. 2 is a bottom, rear, and right side perspective view thereof; FIG. 3 is a left side elevation view thereof; FIG. 4 is a right side elevation view thereof; FIG. 5 is a front elevation view thereof; FIG. 6 is a rear elevation view thereof; FIG. 7 is a top plan view thereof; FIG. 8 is a bottom plan view thereof; FIG. 9 is an enlarged and partial perspective view of area 9 in FIG. 1; FIG. 10 is an enlarged and partial perspective view of area 10 in FIG. 2; FIG. 11 is an enlarged and partial perspective view of area 11 in FIG. 2; FIG. 12 is an enlarged and partial left side elevation view of area 12 in FIG. 3; and, FIG. 13 is an enlarged and partial right side elevation view of area 13 in FIG. 4. The dashed broken lines in the figures are for the purposes of illustrating portions of the children's electric motorcycle, which form no part of the claimed design.
Abstract:
Meta-lens based ocular imaging, near-eye display, and eye-tracking systems are described. The systems can include a single focusing optic and an integrated circuit that provides illumination light and includes an imaging array. The focusing optic includes meta-atoms formed on a substrate. The systems may have no moving parts and achieve imaging or image-projection fields-of-view approaching or exceeding 180 degrees. Because of their low part count, the systems can be robust and have a very small form factor.
Abstract:
Controlling assistance information comprises determining a user mode based on computer input signals generated by a user. If the user is in a passive mode and assistance information is detected, the assistance information is disabled in response to detecting a hidden signal. The assistance information is then enabled if later a reset signal is detected. If the user is in passive mode and assistance information is not detected, the assistance information is enabled in response to detecting a trigger signal. If the user is in an active mode and assistance information is detected, the assistance information is disabled.
Abstract:
A computer-implemented method for assisting a user to input Vietnamese text to a user device lacking a subset of characters in a Vietnamese alphabet includes receiving a character input by a user, determining three words previously input by the user, the three words having already had diacritical marks inserted, transmitting the three words and the character to a server via a network, receiving first and second information corresponding to the character from the server via the network, the first and second information generated at the server based on a context of the three words, the context determined at the server using a language model, the first and second information indicating whether the character requires a diacritical mark and a specific diacritical mark, respectively, generating a modified character comprising a character in the Vietnamese alphabet based on the character and the first and second information, and displaying the modified character.
Abstract:
The present invention is directed to a compound of the formula: or pharmaceutically acceptable salts thereof and use of such compounds for treating proliferative diseases such as cancer, in mammals.
Abstract:
The invention is directed to novel pyrrolopyrimidine compounds of formula (I) wherein R1, R2Y, R4, R8-R11, A and L are defined herein and to salts, including pharmaceutically acceptable salts thereof. The compounds of the present invention are CDK4/6 inhibitors and could be useful in the treatment of diseases and disorders mediated by CDK4/6, such as cancer, including mantle cell lymphoma, liposarcoma, non small cell lung cancer, melanoma, squamous cell esophageal cancer and breast cancer. The invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting CDK4/6 activity and to the treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.
Abstract:
Impregnated rare earth metal-containing barium-aluminum-scandate cathodes with a rare earth oxide doped tungsten matrix and methods for the fabrication thereof are described. In one aspect, an impregnated rare earth metal-containing barium-aluminum-scandate cathode comprises: a rare earth oxide doped tungsten matrix, and an impregnated active substance. The active substance comprises scandium oxide (Sc2O3), a second rare earth oxide, and barium calcium aluminate, wherein the molar ratio of Ba:Ca:Al is about 4:1:1.
Abstract:
The present invention is directed to a compound of the formula: or pharmaceutically acceptable salts thereof and use of such compounds for treating proliferative diseases such as cancer, in mammals.
Abstract:
Systems, devices, and methods for associating network devices with users are described, which can facilitate establishing a secure user to network device association. In various embodiments, the disclosed subject matter facilitates devices providing indication of location and device identity to a user and recognizing the user is in the proximity of the device. The disclosed subject matter provides efficient and secure device to user association and can facilitate performing customized actions based on the nature of the association.